HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hamburg Joins Sharfstein On FDA Commissioner Shortlist

This article was originally published in The Rose Sheet

Executive Summary

The removal of Duke University cardiologist Robert Califf's name from consideration for FDA commissioner indicates that a record of government service and a strong public health background will trump all other qualifications for the post
Advertisement

Related Content

Nominations To Lead FDA Coming Soon For Hamburg And Sharfstein
Nominations To Lead FDA Coming Soon For Hamburg And Sharfstein
Obama Wants FDA’s “Full Review” As Recall Of Peanut Butter Items Goes On
Obama Wants FDA’s “Full Review” As Recall Of Peanut Butter Items Goes On
Advertisement
UsernamePublicRestriction

Register

RS015979

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel